THURSDAY, Sept. 13, 2018 -- Users of valsartan contaminated with N-nitrosodimethylamine (NDMA) seem not to have increased cancer risk, according to a study published online Sept. 12 in The BMJ. Anton Pottegård, Ph.D., from the University of...
Original Article: No Apparent Short-Term Cancer Risk From Recalled Valsartan